Byron C.H. Chu

1.0k citations
14 papers · 793 indexed · h-index 12

Impact in

Papers in

Byron C.H. Chu

14 papers receiving 779 citations

Peers

Byron C.H. Chu
Comparison fields: 5 of 89
  • Molecular Medicine 98
  • Endocrinology 85
  • Molecular Biology 499
  • Hematology 67
  • Genetics 163
Replace Hossein Abdul-Tehrani with:
Hossein Abdul-Tehrani Iran
Sujuan Xu China
Elaine R. Frawley United States
Jung‐Ho Shin United States
E.V. Blagova United Kingdom
Emily A. Dertz United States
Zachery R. Lonergan United States
Mark Shepherd United Kingdom
Erin L. Mettert United States
J.C. Grigg Canada
Byron C.H. Chu relative to Hossein Abdul-Tehrani Iran Hossein Abdul-Tehrani's profile →
Citations per field
00.5×2.7×
Hossein Abdul-Tehrani · 1×
Citations per year

Countries citing papers authored by Byron C.H. Chu

Since Specialization
Citations

This map shows the geographic impact of Byron C.H. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byron C.H. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byron C.H. Chu more than expected).

Fields of papers citing papers by Byron C.H. Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byron C.H. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byron C.H. Chu. The network helps show where Byron C.H. Chu may publish in the future.

Co-authors

The 24 scholars most cited alongside Byron C.H. Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Byron C.H. Chu Line = papers co-authored together Byron C.H. Chu links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 201521
2 201428
3 201327
4 201311
5 201156
6 2010255
7 201015
8 201056
9 200971
10 20092
11 2007177
12 200758
13 20064
14 200312

About Byron C.H. Chu

Byron C.H. Chu is a scholar working on Genetics, Molecular Medicine, Endocrinology, Oncology and Biochemistry, having authored 14 papers that have together received 793 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (6 papers), Protein Structure and Dynamics (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Enzyme Structure and Function (4 papers), Porphyrin Metabolism and Disorders (2 papers), Trace Elements in Health (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Molecular Medicine (98 citations), Endocrinology (85 citations), Molecular Biology (499 citations), Hematology (67 citations) and Genetics (163 citations). Byron C.H. Chu has collaborated with scholars based in Canada, Netherlands and Denmark. Frequent co-authors include Hans J. Vogel, Hung Lee, R. Sean Peacock, Karla D. Krewulak, Cheryl K. Lau, Alicia Garcı́a-Herrero, Ted Johanson, Renee Otten, Frans A. A. Mulder and Marion Sparrius. Their work appears in journals such as Journal of Biological Chemistry, BioMetals, PLoS Pathogens, Journal of the American Chemical Society and Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026